Reduction of cardiovascular risk factors by the diet – Evaluation of the MoKaRi concept by a parallel-designed randomized study.

Authors: Dawczynski, Christine^1,2 (AUTHOR) christine.dawczynski@uni-jena.de, Drobner, Timo^1,2 (AUTHOR) timo.drobner@uni-jena.de, Weidauer, Thomas^1,2 (AUTHOR) thweidauer@gmail.com, Schlattmann, Peter³ (AUTHOR) peter.schlattmann@med.uni-jena.de, Kiehntopf, Michael⁴ (AUTHOR) michael.kiehntopf@med.uni-jena.de, Weber, Daniela^5,6,7 (AUTHOR) daniela.weber@dife.de, Grune, Tilman^5,6 (AUTHOR) scientific.director@dife.de, März, Winfried^7,8 (AUTHOR) winfried.maerz@synlab.com, Kleber, Marcus E.⁹ (AUTHOR) marcus.kleber@medma.uni-heidelberg.de, Lorkowski, Stefan^2,10 (AUTHOR) stefan.lorkowski@uni-jena.de

Source: Lipids in Health & Disease. 3/8/2025, Vol. 24 Issue 1, p1-29. 29p.

Subject Terms: *LDL cholesterol, *DIASTOLIC blood pressure, *CARDIOVASCULAR diseases risk factors, *FISH oils, *FAT

Genetic screening of malay familial hypercholesterolemia patient for LDLRAP1/PCSK9/APOB mutations via whole exome sequencing.

Authors: Abdullah-Zawawi, Muhammad-Redha¹ (AUTHOR), Mohd Rani, Zam Zureena¹ (AUTHOR), Seeni Ahamed Mydeen, Nur Syakeera¹ (AUTHOR), Mohd Yunos, Ryia Illani¹ (AUTHOR), Sulaiman, Siti Aishah¹ (AUTHOR), Badaruddin, Izzatul 'Aliaa² (AUTHOR), Ismet, Rose³ (AUTHOR), Mustafa, Norlaila⁴ (AUTHOR), Abu Zahid, Syahidatun Najwa¹ (AUTHOR), Jamal, Rahman¹ (AUTHOR), Hamzah, Azrul Azlan⁵ (AUTHOR), Abdul Murad, Nor Azian¹ (AUTHOR) nor_azian@ppukm.ukm.edu.my

Source: Egyptian Journal of Medical Human Genetics. 3/3/2025, Vol. 26 Issue 1, p1-16. 16p.

Subject Terms: *LDL cholesterol, *FAMILIAL hypercholesterolemia, *PROTEIN structure, *GENETIC testing, *HEREDITY

Formation of PEG-PLGA Microspheres for Controlled Release of Simvastatin and Carvacrol: Enhanced Lipid-Lowering Efficacy and Improved Patient Compliance in Hyperlipidemia Therapy.

Authors: Fu, Lin¹ (AUTHOR), Ren, Hengxin^1,2 (AUTHOR), Wang, Chaoxing¹ (AUTHOR), Zhao, Yaxin² (AUTHOR), Zou, Bohang¹ (AUTHOR), Zhang, Xiangyu¹ (AUTHOR) zhangxy@jmsu.edu.cn

Source: Polymers (20734360). Mar2025, Vol. 17 Issue 5, p574. 17p.

Subject Terms: *DRUG side effects, *LDL cholesterol, *PATIENT compliance, *CARVACROL, *DRUG control, *HYPERLIPIDEMIA, *SIMVASTATIN

Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database.

Authors: Rossi, Antonio^1,2 (AUTHOR) antonio.rossi1@unimi.it, Masi, Davide³ (AUTHOR) davide.masi@uniroma1.it, Zilich, Rita⁴ (AUTHOR) rita.zilich@mix-x.com, Baccetti, Fabio⁵ (AUTHOR) fabio.baccetti@uslnordovest.toscana.it, Baronti, Walter⁶ (AUTHOR) walter.baronti@uslsudest.toscana.it, Falcetta, Pierpaolo⁷ (AUTHOR) pierpaolo.falcetta@phd.unipi.it, Morviducci, Lelio⁸ (AUTHOR) leliomorviducci@gmail.com, Musacchio, Nicoletta⁹ (AUTHOR) nicoletta.musacchio@gmail.com, Muselli, Marco¹⁰ (AUTHOR) marco.muselli@ieiit.cnr.it, Ozzello, Alessandro¹¹ (AUTHOR) ozzelloa@gmail.com, Salomone, Enrica⁸ (AUTHOR) enrica.salomone@aslroma1.it, Verda, Damiano¹⁰ (AUTHOR) damiano.verda@gmail.com, Vezenkova, Maria¹² (AUTHOR) v.maria@e-deimos.it, Candido, Riccardo¹³ (AUTHOR) riccardocandido67@gmail.com, Ponzani, Paola¹⁴ (AUTHOR) paola.ponzani@gmail.com

Source: Cardiovascular Diabetology. 2/28/2025, Vol. 24 Issue 1, p1-13. 13p.

Subject Terms: *LDL cholesterol, *TYPE 2 diabetes, *CARDIOVASCULAR diseases risk factors, *MEDICAL databases, *EDUCATIONAL attainment

A LASSO-derived model for the prediction of nonattainment of target LDL-C reduction with PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease.

Authors: Duan, Xiaochun¹ (AUTHOR), Zhang, Mengdi^2,3 (AUTHOR), Sun, Xiaodong² (AUTHOR), Lin, Yang² (AUTHOR), Peng, Wenxing² (AUTHOR) shouyipwx@163.com

Source: Lipids in Health & Disease. 2/21/2025, Vol. 24 Issue 1, p1-9. 9p.

Subject Terms: *LDL cholesterol, *DIASTOLIC blood pressure, *RECEIVER operating characteristic curves, *DECISION making, *STATINS (Cardiovascular agents), *ALANINE aminotransferase

Statin use and low-density lipoprotein cholesterol target achievement for primary prevention of atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus: a multicenter cross-sectional study in Sri Lanka.

Authors: De Zoysa, P.D.W.D.¹ (AUTHOR) warshadez@gmail.com, Weerarathna, T.P.¹ (AUTHOR), Darshana, I.L.A.N.¹ (AUTHOR), Wasana, K.G.P.² (AUTHOR), Piyasekara, B.³ (AUTHOR), Jayasekara, M.M.P.T.⁴ (AUTHOR), Sujanitha, V.⁵ (AUTHOR), Silva, S.⁶ (AUTHOR), Mettananda, C.⁷ (AUTHOR), Ramadasa, G.U.⁸ (AUTHOR), Pathirage, L.P.M.M.K.⁹ (AUTHOR)

Source: PLoS ONE. 2/21/2025, Vol. 20 Issue 2, p1-16. 16p.

Subject Terms: *TYPE 2 diabetes, *LDL cholesterol, *MULTIPLE regression analysis, *TERTIARY care, *GLYCEMIC control

Elevated thrombosis-related biomarkers as predictors of disease severity and mortality in patients with severe fever with thrombocytopenia syndrome.

Authors: Lu, Ting¹ (AUTHOR), Yan, Hong² (AUTHOR), Luo, Jie³ (AUTHOR), Wang, Sen¹ (AUTHOR), Xia, Yanyan¹ (AUTHOR) xiayanyansy@qq.com, Xu, Xuejing¹ (AUTHOR) 81597109@qq.com

Source: BMC Infectious Diseases. 2/18/2025, Vol. 25 Issue 1, p1-10. 10p.

Subject Terms: *HDL cholesterol, *LDL cholesterol, *TISSUE plasminogen activator, *PLASMINOGEN activator inhibitors, *RECEIVER operating characteristic curves, *DEATH forecasting

Low-Dose Docetaxel Is Effective in Reducing Atherogenic Lipids and Atherosclerosis.

Authors: Choi, Hong Y.¹ (AUTHOR) hong.choi2@affiliate.mcgill.ca, Ruel, Isabelle^1,2 (AUTHOR), Choi, Shiwon¹ (AUTHOR), Iatan, Iulia^1,2 (AUTHOR), Choi, Senna¹ (AUTHOR), Lee, Jyh-Yeuan² (AUTHOR), Genest, Jacques¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 4, p1484. 16p.

Subject Terms: *LDL cholesterol, *BLOOD lipids, *HDL cholesterol, *HIGH density lipoproteins, *SINUS of valsalva

Clonal hematopoiesis of indeterminate potential, health indicators, and risk of cardiovascular diseases among patients with diabetes: a prospective cohort study.

Authors: Sun, Ying¹ (AUTHOR), Yu, Yuefeng¹ (AUTHOR), Cai, Lingli¹ (AUTHOR), Yu, Bowei¹ (AUTHOR), Xiao, Wenying² (AUTHOR), Tan, Xiao^3,4 (AUTHOR), Wang, Yu² (AUTHOR) wangyushidonghos@163.com, Lu, Yingli¹ (AUTHOR), Wang, Ningjian¹ (AUTHOR) wnj486@126.com

Source: Cardiovascular Diabetology. 2/13/2025, Vol. 24 Issue 1, p1-12. 12p.

Subject Terms: *LDL cholesterol, *HEALTH status indicators, *CORONARY disease, *BODY mass index, *MEDICAL sciences

Low-density lipoprotein cholesterol predicts coronary artery calcification events in patients with type 2 diabetes: a longitudinal study.

Authors: Zou, Zhi¹ (AUTHOR) zouzhi99@163.com, Sun, Yongbing¹ (AUTHOR) ybsun8788@163.com, Zou, Lijun² (AUTHOR) 918746181@qq.com, Zhou, Yang¹ (AUTHOR) 2905727300@qq.com, Lin, Xinbei¹ (AUTHOR) xinbei0820@163.com, Zhou, Jing³ (AUTHOR) jzhou128@126.com, Li, Zhonglin¹ (AUTHOR) zhonglinlixd@163.com, Wu, Xiaoling⁴ (AUTHOR) wxl19910316@163.com, Wang, Ling¹ (AUTHOR) wangling1339@126.com, Li, Xiaodong¹ (AUTHOR) 1301067844@qq.com, Wang, Yong⁵ (AUTHOR) 408036168@qq.com, Hu, Yangxi⁶ (AUTHOR) huyangxi2046@163.com, Li, Fengli⁶ (AUTHOR) 529036465@qq.com, Zhang, Jiancheng⁷ (AUTHOR) 596473537@qq.com, Li, Yongli⁸ (AUTHOR) shyliyongli@126.com

Source: Diabetology & Metabolic Syndrome. 2/12/2025, Vol. 17 Issue 1, p1-9. 9p.

Subject Terms: *CORONARY artery calcification, *LDL cholesterol, *PROPORTIONAL hazards models, *TYPE 2 diabetes, *CARDIOVASCULAR diseases risk factors

High mean corpuscular volume as a predictor of esophageal cancer: A cohort study based on the Japanese Shizuoka Kokuho Database.

Authors: Sato, Shinsuke^1,2 (AUTHOR), Ohata, Emi^2,3 (AUTHOR), Nakatani, Eiji^2,4 (AUTHOR), Hawke, Philip⁵ (AUTHOR), Sasaki, Hatoko² (AUTHOR), Nagai, Erina¹ (AUTHOR), Taki, Yusuke¹ (AUTHOR), Nishida, Masato¹ (AUTHOR), Watanabe, Masaya¹ (AUTHOR), Ohata, Ko¹ (AUTHOR), Kanemoto, Hideyuki¹ (AUTHOR), Sugawara, Akira² (AUTHOR) asugawara@s-sph.ac.jp

Source: PLoS ONE. 2/11/2025, Vol. 20 Issue 2, p1-16. 16p.

Subject Terms: *ALCOHOLISM, *LDL cholesterol, *ESOPHAGEAL cancer, *SYSTOLIC blood pressure, *REFERENCE values

Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk.

Authors: Wang, Zeyu^1,2 (AUTHOR), Yin, Zixiao^3,4 (AUTHOR), Sun, Guangyong^1,2 (AUTHOR), Zhang, Dong^1,2 (AUTHOR) zhangd2010@hotmail.com, Zhang, Jianguo^3,4 (AUTHOR) zjguo73@126.com

Source: Lipids in Health & Disease. 2/8/2025, Vol. 24 Issue 1, p1-14. 14p.

Subject Terms: *LDL cholesterol, *MENDELIAN randomization, *LIPID metabolism, *ALZHEIMER'S disease, *AMYOTROPHIC lateral sclerosis

Remnant cholesterol and its variability independent of low density lipoprotein cholesterol predict metabolic dysfunction associated steatotic liver disease.

Authors: Sun, Yuting^1,2 (AUTHOR), Miao, Xinlei¹ (AUTHOR), Hu, Manling^1,2 (AUTHOR), Xie, Xiaoling^1,3 (AUTHOR), Liu, Shuang^1,3 (AUTHOR), Song, Ziping^1,2 (AUTHOR), Deng, Jiayi^1,2 (AUTHOR), Xu, Fei^1,3 (AUTHOR), Li, Meng^1,3 (AUTHOR), He, Yangxuan^1,2 (AUTHOR), Leng, Song^1,2 (AUTHOR) dllengsong@163.com

Source: Scientific Reports. 2/6/2025, Vol. 15 Issue 1, p1-11. 11p.

Subject Terms: *LDL cholesterol, *METABOLIC disorders, *LIPID analysis, *LIVER diseases, *CHOLESTEROL

The relationship between the intake of fruits, vegetables, and dairy products and dyslipidemia in STEPs study.

Authors: Nouri, Mehran^1,2 (AUTHOR) mehran_nouri71@yahoo.com, Ebrahimi, Zohreh³ (AUTHOR) msebrahimi@gmail.com, Shateri, Zainab⁴ (AUTHOR) zainabshateri@gmail.com, Faghih, Shiva^2,5 (AUTHOR) shivafaghih@gmail.com

Source: BMC Research Notes. 2/7/2025, Vol. 18 Issue 1, p1-12. 12p.

Subject Terms: *HDL cholesterol, *LDL cholesterol, *BLOOD lipids, *HIGH density lipoproteins, *DAIRY products

The diagnostic value of the combined application of blood lipid metabolism markers and interleukin-6 in osteoporosis and osteopenia.

Authors: Fan, Liping¹ (AUTHOR), Chen, Jiahao² (AUTHOR), Chen, Chong¹ (AUTHOR), Zhang, Yongwei¹ (AUTHOR), Yang, Yeqing¹ (AUTHOR), Chen, Zhe³ (AUTHOR) zhechen@zcmu.edu.cn

Source: Lipids in Health & Disease. 2/5/2025, Vol. 24 Issue 1, p1-17. 17p.

Subject Terms: *LDL cholesterol, *PEPTIDES, *BLOOD lipids, *APOLIPOPROTEIN B, *BONE density, *TERIPARATIDE

Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature.

Authors: Sheashaa, Hesham¹ (AUTHOR) sheashaa.hesham@mayo.edu, Mousa, Hana¹ (AUTHOR), Abbas, Mohammed Tiseer¹ (AUTHOR), Farina, Juan M.¹ (AUTHOR), Awad, Kamal¹ (AUTHOR), Pereyra, Milagros¹ (AUTHOR), Scalia, Isabel G.¹ (AUTHOR), Ali, Nima Baba¹ (AUTHOR), Javadi, Niloofar¹ (AUTHOR), Bismee, Nadera N.¹ (AUTHOR), Esfahani, Sogol Attaripour¹ (AUTHOR), Ibrahim, Omar¹ (AUTHOR), Abdelfattah, Fatmaelzahraa¹ (AUTHOR), Ibrahim, Ramzi¹ (AUTHOR), Abdelnabi, Mahmoud¹ (AUTHOR), Ayoub, Chadi¹ (AUTHOR), Arsanjani, Reza¹ (AUTHOR) arsanjani.reza@mayo.edu

Source: Biomolecules (2218-273X). Feb2025, Vol. 15 Issue 2, p162. 20p.

Subject Terms: *DISEASE risk factors, *LDL cholesterol, *HIGH density lipoproteins, *MENDELIAN randomization, MORTALITY risk factors

A Comparative Effect of 12-Week Dietary Intervention of Policosanol (Raydel ®) and Red Yeast Rice (RYR, Kobayashi) in Managing Dyslipidemia and Organ Damage in Hyperlipidemic Zebrafish.

Authors: Cho, Kyung-Hyun¹ (AUTHOR) chok@raydel.co.kr, Bahuguna, Ashutosh¹ (AUTHOR), Kim, Ji-Eun¹ (AUTHOR), Lee, Sang Hyuk¹ (AUTHOR), Lee, Yunki¹ (AUTHOR), Jeon, Cheolmin¹ (AUTHOR)

Source: Pharmaceuticals (14248247). Feb2025, Vol. 18 Issue 2, p200. 24p.

Subject Terms: *HDL cholesterol, *LDL cholesterol, *GENITALIA, *MONASCUS purpureus, *HIGH cholesterol diet

HDL proteome and apolipoproteins concentrations in severe ICU COVID-19 patients.

Authors: Begue, Floran^1,2 (AUTHOR), Veeren, Bryan¹ (AUTHOR), Rondeau, Philippe¹ (AUTHOR), Florence, Aline-Marie^3,4 (AUTHOR), Jamard, Simon⁵ (AUTHOR), Montravers, Philippe^6,7,8 (AUTHOR), Tanaka, Sébastien^1,6 (AUTHOR), Meilhac, Olivier^1,9 (AUTHOR) olivier.meilhac@inserm.fr

Source: Lipids in Health & Disease. 1/31/2025, Vol. 24 Issue 1, p1-13. 13p.

Subject Terms: *COVID-19 pandemic, *LDL cholesterol, *COVID-19, *INDUCTIVELY coupled plasma mass spectrometry, *POLYACRYLAMIDE gel electrophoresis

Evolocumab safety and efficacy in hypercholesteremia patients with or without diabetes: a retrospective real-world analysis.

Authors: Alraddadi, Sultan Ibrahim^1,2,3 (AUTHOR) RaddadiS@MNGHA.MED.SA, Almodaimegh, Hind^1,2,3 (AUTHOR), Kharbosh, Abdullah⁴ (AUTHOR), Alharbi, Hadeel^1,3 (AUTHOR), Fathelrahman, Ahmed Ibrahim⁴ (AUTHOR), Alsheikh, Mona Yaser⁵ (AUTHOR), Alfehaid, Lama^1,2,3 (AUTHOR)

Source: Diabetology & Metabolic Syndrome. 1/31/2025, Vol. 17 Issue 1, p1-12. 12p.

Subject Terms: *GLYCEMIC control, *LDL cholesterol, *MEDICAL sciences, *PEOPLE with diabetes, *PATIENT safety

Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study.

Authors: Li, Nan¹ (AUTHOR), Liu, Chenbing¹ (AUTHOR), Lu, Zhangfan¹ (AUTHOR), Wu, Wenjian¹ (AUTHOR), Zhang, Feng¹ (AUTHOR), Qiu, Lihong¹ (AUTHOR), Shen, Chao¹ (AUTHOR), Sheng, Di¹ (AUTHOR), Liu, Zhong¹ (AUTHOR) liuzhongzheyi@zju.edu.cn

Source: BMC Gastroenterology. 1/28/2025, Vol. 25 Issue 1, p1-11. 11p.

Subject Terms: *HDL cholesterol, *LDL cholesterol, *LEUKOCYTES, *BODY mass index, *BLOOD sugar